Suggestions
Dr. Berra Yazar-Klosinski
Chief Scientific Officer at Lykos Therapeutics (formerly MAPS PBC)
Dr. Berra Yazar-Klosinski is a highly accomplished professional with a diverse educational background and extensive experience in the fields of biochemistry, biophysical methods, genetics, and molecular biology.
She holds a Ph.D. in biochemistry and has studied at renowned institutions such as the University of California, Santa Cruz, and Stanford University where she earned a B.S. in Biological Sciences.
Dr. Yazar-Klosinski has held key positions in various prestigious organizations like Lykos Therapeutics (formerly MAPS PBC) where she served as the Chief Scientific Officer. Additionally, she has taken on roles such as Deputy Director, Director of Research Development & Regulatory Affairs, Associate Director of Clinical Research, and Clinical Research Scientist at the Multidisciplinary Association for Psychedelic Studies (MAPS).
Prior to her engagements at MAPS, Dr. Yazar-Klosinski contributed significantly to research and development at the Hartzog Lab, and as a Research Associate at Millennium Pharmaceuticals and Geron Corporation.
Her expertise spans across multiple areas within the scientific realm, making her a seasoned professional in the field of biochemistry, genetics, and pharmaceutical research.
Highlights
